GMPharm

Skip to content

CHECKED

Companies Insolvencies Sectors Watchlist Alerts API

Sign in

GMPharm

Perwez ·KBO/BCE: BE 0781.862.362

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility Decision tools Company map

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Developers Badge Business information compared Free company information

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Your question travels, with the dossier's public data, to our AI model at Anthropic in the US. Nothing that identifies you goes along, and we keep neither question nor answer. Answers can be wrong, so this is not legal advice. How it works

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	30-04-2026	92 d early	2026-00098999
31-12-2024	31-07-2025	26-06-2025	35 d early	2025-00196115
31-12-2023	31-07-2024	07-06-2024	54 d early	2024-00127097
31-12-2022	31-07-2023	30-06-2023	31 d early	2023-00201200

Metric	This company	Sector median	Position in the sector
Solvency	81.2%	53.8%	better than 81% of 56 sector peers
Net result	€55k	€24k	better than 60% of 56 sector peers
Equity	€175k	€50k	better than 79% of 56 sector peers
Gross operating margin	€73k	€49k	better than 55% of 56 sector peers
Total assets	€216k	€158k	better than 59% of 56 sector peers

Fiscal year	2025
Deposit	micro
Revenue	-
EBITDA	€73k
Net profit	€55k
Cash flow	€58k
Staff costs	-
Income taxes	€15k
Dividends	€12k
Total assets	€216k
Equity	€175k
Debt	€41k
of which ≤ 1y	€41k
of which > 1y	-
Working capital	€167k
Employees (FTE)	-

	2025
Current ratio	5.12
Quick ratio	5.12
Working capital ratio	77.5%
Solvency	81.2%
Debt / equity	0.23
Long-term debt ratio	-
Interest coverage	1695.24
Gross margin	-
Net margin	-
ROA	25.7%
ROE	31.7%
EBITDA margin	-
Days sales outstanding	-
Days payable outstanding	-
Inventory turnover	-
Days inventory (DSI)	-

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€216k
Fixed assets	21/28	€8k
Tangible fixed assets	22/27	€2k
Financial fixed assets	28	€6k
Current assets	29/58	€208k
Amounts receivable within one year	40/41	€44k
Cash & bank	54/58	€162k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€216k
Equity	10/15	€175k
Contributions / capital	10/11	€3k
Accumulated profits (losses)	14	€173k
Amounts payable	17/49	€41k
Amounts payable within one year	42/48	€41k
Trade debts payable within one year	44	€543
Income statement
Gross operating margin	9900	€73k
Operating result	9901	€70k
Financial income	75	€7
Financial charges	65	€43
Result before taxes	9903	€70k
Income taxes	67/77	€15k
Net result for the period	9904	€55k
Result to be appropriated	9905	€55k

Summary

Conclusion

Signals

Filing behaviour

Trust signals

Administrative Flags

Bankruptcy probability (12 mo)

Financials

Annual accounts & ratios

Health barometer

Structure & network

Locations & real estate

Registered office

Establishment units

Real-estate footprint

Publications

Lifecycle & Insolvency Signals

Belgian State Gazette · acts

Analysis

Snowflake analysis

Ask AI about this company

AI due-diligence brief

Credit advice

Similar

Similar companies

Company registry

Company registry (CBE)